how does tirzepatide cause pancreatitis in Patients Receiving (Mounjaro): A One-Year Audit in a UK District General Hospital Tirzepatide and Pancreatitis Risk: What

Given the established physiological effects of GIP receptor activation, GIP receptor antagonism could potentially lead to undesirable increases in blood glucose levels due to reduced insulin secretion

Honestly, the population-level evidence picture is thin

95% CI 0.93, 1.01), MACE (HR 0.95

Mitochondrial Health Mitochondria are the engines of our cells, producing our primary form of energy currency, ATP

Plain water remains appropriate for routine hydration, but low-sugar electrolyte solutions become important during active losses

Serious adverse events and mortality Incidence of serious adverse events did not differ between any of the tirzepatide doses and any comparator (ESM Table 3)